The role of microglia reactivity in the cerebral pathology in schizophrenia

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 109, Issue 3, 2009, Pages 60-63

  Kolomeets, N S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65749115650     PISSN: 19977298     EISSN: 19977298     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Russian Source.
2. Russian Source.
3. Russian Source.
4. Russian Source.
5. Russian Source.
6. Russian Source.
7. Russian Source.
8. Arnold S.E., Trojanowski J.Q., GurR.E. et al. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiat 1998; 55: 225-232.
9. Avgustin B., Wraber B., Tavear R. Increased Th 1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat Med J 2005; 46: 2: 268-274.
10. Banati R.B. Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. Br Med Bulletin 2003; 65: 121-131.
11. Bayer T.A., Buslei R., Havas L.et al. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci Lett 1999; 271: 2: 126-128.
12. Bian O., Kato 73, Hashioka S. et al. The effect of atypical antipsychotics, perospirone, ziprazidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsycopharmacol Biol Psychiat 2008; 32: 42-48.
13. Buttini M., Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rat brain microglial cells. Neuroscience 1995; 65: 523-530.
14. Cheepsunthorn P., Radov L., Menzies S. et al. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001; 35: 53-62.
15. Christensen R.N., Ha B.K., Sun F, Bresnahan J.C.et al. Kainate induces rapid redistribution of the actin cytoskeleton in ameboid microglia. J Neurosci Res 2006; 84: 1:170-181.
16. Cicchetti E, Lapointe N., Roberge-Tremblay A. et al. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol. Dis 2005; 20: 360-371.
17. De Groot C.J., Huppes W., Sminia T.et al. Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous system, using non-radioactive in situ hybridization and immunoperoxidase techniques. Glia 1992; 6: 301-309.
18. Foster R., Kandanearatchi A., Beastey C. et al. Calprotectin in microglia from frontal cortex is up-regulated in schizophrenia: evidence for an inflammatory process? Eur J Neurosci 2006; 24: 12: 3561-3566.
19. Frank O., Giehl M., Zheng C. et al. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virology 2005; 79: 17: 10890-10901.
20. Ganguli R., BrarJ.S., Chengappa K.R. et al. Mitogen-stimulated interleukin 2 production in never-medicated first episode schizophrenics-the influence of age of onset and negative symptoms. Arch Gen Psychiat 1995; 52: 668-672.
21. GoffD. C, CoyleJ. T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiat 2001; 158: 1367-1377.
22. Gras G, Poreheray F, Samah B., Leone C. The glutamate-glutamine cycle as an inducible, protective face of macrophage activation. J Leukoc Biol 2006; 80: 5: 1067-1075.
23. Guillemin G.J., Brew B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004; 75: 388-397.
24. Hayashi ¥., Ishibashi H, Hashimoto K. et al. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia 2006; 53:6: 660-668.
25. lh biennial winter workshop on schizophrenia. Davos, Switzerland. Schizopr Res 2004; 67: 103.
26. Hou Y., Wu C.F., Yang J.Y. et al. Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells. Prog Neuropsychopharmacol Biol Psychiat 2006; 30: 8:1523-1528.
27. Karlsson H, Bachmann S.J., Schroder J. et al. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Nat Acad Sci USA 2001; 98:4634-4639.
28. Kato T., Monji A., Hashioka S. et al. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res 2007; 92: 1-3: 108-115.
29. Kim Y.S., Joh T.H. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Molec Med 2006; 38: 4: 333-347.
30. Lewandowska E., Wierzba-Bobrowicz T., Kosno-Kruszewska E. et al. Ultrastructural evaluation of activated forms of microglia in human brain in selected neurological diseases (SSPE, Wilson's disease and Alzheimer's disease). Folia Neuropathol 2004; 42: 2: 81-91.
31. Liu B. Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J 2006; 8: 3: 606-621.
32. Lu Y.Z., Lin C.H., Cheng FC. et al. Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci Lett 2005; 373: 2:159-164.
33. Mittelbronn M., DietzK., SchluesenerH. J., Meyermann R. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magniture. Acta Neuropathol 2001; 101: 249-255.
34. Muller N., Riedel M., Ackenheil U., Schwarz M.J. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiat 2000; 1: 173-179.
35. Munn N.A. Microglia dysfunction in schizophrenia: an integrative theory. Med Hypotheses 2000; 54: 2: 198-202.
36. Nakajima K., Kohsaka S. Functional roles of microglia in the brain. Neurosci Res 1993; 17: 187-203.
37. Neumann H. Control of glial immune function by neurons. Glia 2001; 36: 191-199.
38. Nikkila H V., Muller K., Ahokas A. et al. Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am J Psychiat 1999; 156: 11: 1725-1729.
39. Nikkila H. V., Mutter K., Ahokas A. el al. Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res 2001; 49: 1-2: 99-105.
40. Noda M., Nakanishi H., Nabekura J. et al. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 2000; 20: 1: 251-258.
41. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004; 173: 3916-3924.
42. Ovanesov M. V, Sauder C, Rubin S.A. et at. Activation of microglia by borna disease virus infection: in vitro study. J Virol 2006; 80: 12141-12148.
43. Pyo H., Joe E., Jung S. et al. Gangliosides activate cultured rat brain microglia. J Biol Chem 1999; 274: 34584-34589.
44. Rosoklija G, Toomayan G, Ellis S.Ret al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiat 2000; 57: 349-356.
45. Senitz D., Beckmann H. Granule cells of the dentate gyrus with basal and recurrent dendrites in schizophrenic patients and controls. A comparative Golgi study. J Neural Transm 2003; 110: 317-326.
46. SteffekA.E., Haroutunian V., Meador-Woodruff J.H. Serine racemase protein expression in cortex and hippocampus in schizophrenia. Neuroreport 2006; 17: 1181-1185.
47. SteinerJ., Mawrin C, Ziegeler A. et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathologica 2006; 112: 305-316.
48. Steiner J., Bielau H., Brisch R. et al. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiat Res 2008; 42:66-72.
49. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 2006; 27: 2: 71-80.
50. Tai Y. E, Pavese N., Gerhard A. et al. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007; 30: 1759-1766.
51. Tanaka J., Toku K., Matsuda S. et al. Induction of resting microglia in culture medium devoid of glycine and serine. Glia 1998; 24: 2: 198-215.
52. Togo T, Akiyama H., Kondo H. et al. Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. Brain Res 2000; 885: 117-121.
53. Town T, Nikolic V., Tan J. The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation 2005; 2: 24.
54. Van Berckel., Boellaard R., Caspers E. et al. Microglia activation in schizophrenia: an (R)-[11C]-PK11195 positron emission tomography study. Abstract from the 2005 international congress on schizophrenia research. Savannah, Georgia. Schizophr Bull 2005; 31:448.
55. van Berckel B.H., Bossong M., Boellaard R. et al. Microglial activation in recent-onset schizophrenia: a quantitative ®-[HC]PK11195 positron emission tomography study. Biol Psychiat 2008; 64: 820-822.
56. Wierzba-Bobrowicz T, Gwiazda E., Kosno-Kruszewska E. et al. Morphological analysis of active microglia-rod and ramified microglia in human brains affected by some neurological diseases (SSPE, Alzheimer's disease and Wilson's disease). Folia Neuropathol 2002; 40: 3: 125-131.
57. Xue Q.S., Sparks D.L., Streit W.J. Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production. J Neuroinflammation 2007; 4: 20-29.
58. Yamada J., Sawada M., Nakanishi H. Cell cycle-dependent regulation of kainate-induced inward currents in microglia. Biochem Biophys Res Commun 2006; 349: 3: 913-919.
59. Yebra L., Malpesa Y., Ursu G. et al. Dissociation between hippocampal neuronal loss, astroglial and microglial reactivity after pharmacologically induced reverse glutamate transport. Neurochem Int 2006; 49: 7: 691-697.
60. Zhang Z, Chopp M., Powers C. Temporal profile of microglial response following transient (2h) middle cerebral artery occlusion. Brain Res 1997; 744: 189-198.
61. Zhao W, Xie W, Le W et al. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 2004; 63: 9: 964-977.
62. Zietlow R., Dunnett S.B., Fawcett J. W The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur J Neurosci 1999; 11:5:1657-1667.